Dr. Amit Bar-Or, FRCP, MD is a null in Philadelphia, PA specializing in psychiatry & neurology. He graduated from McGill University in 1993 and has 32 years of experience. Dr. Amit Bar-Or, FRCP, MD is affiliated with The Children's Hospital of Philadelphia, UNIVERSITY OF PENN - MEDICAL GROUP and Penn Neuroscience Center - Neurology.
3400 Civic Center Boulevard
Philadelphia, PA 19104
Volume of procedures performed by Dr. Amit Bar-Or, FRCP, MD for Medicare patients.
The highest averages for the top procedures that Dr. Amit Bar-Or, FRCP, MD treated as a null in Philadelphia, PA were hospital care and inpatient care.
| 10 | |
| 10 | |
| 10 |
Information about Medicare patients treated by Dr. Amit Bar-Or, FRCP, MD.
| 3 | |
| 3 |
| 2 | |
| 1 |
The highest averages of the most common conditions of Medicare patients that Dr. Amit Bar-Or, FRCP, MD treated were hypertension, high cholesterol, chronic kidney disease and heart failure.
| 27 | |
| 10 | |
| 4 | |
| 3 | |
| 5 | |
| 4 | |
| 3 |
Dr. Amit Bar-Or, FRCP, MD graduated from McGill University in 1993. He completed residency at Massachusetts General Hospital. He has a state license in Pennsylvania.
Medical School: McGill University (1993)
Residency: Massachusetts General Hospital (1997)
Licensed In: Pennsylvania
Dr. Amit Bar-Or, FRCP, MD is associated with these hospitals and organizations:
Dr. Amit Bar-Or, FRCP, MD appears to accept the following insurance providers: Horizon Blue Cross Blue Shield of New Jersey, Cigna Medicare, HealthSmart, Highmark Blue Shield, UnitedHealthcare Community Plan PA, Aetna, Tricare, Oxford Health Plan, PA Medicare, PA Medicaid, Humana / Medicare, HealthAmerica / HealthAssurance, a Coventry Plan, Cigna, PA Health and Wellness (Centene) Medicare, Geisinger Health Plan, US Family Health Plan, HealthPartners, Independence Blue Cross (Keystone East), Keystone First, UPMC Health Plan, NJ Qualcare, Imagine Health 360, Jefferson Health Plans (fka Health Partners Plans), Clover Health Plan, Keystone First Medicare, Centivo Health Plan, Provider Partners Health Plan, Global Medical Management, Oscar Health Plan of PA, Veterans Choice Program, Highmark Blue Shield Medicare, Claim Watcher (Homestead/Index), Rail Road Medicare / Palmetto GBA and Highmark Wholecare.
According to our sources, Dr. Amit Bar-Or, FRCP, MD accepts the following insurance providers:
Dr. Amit Bar-Or, FRCP, MD does not have any reviews yet, be the first to leave a review of Dr. Amit Bar-Or, FRCP, MD here: Leave a Review
These charts describe general payments received by Dr. Amit Bar-Or, FRCP, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$92,267
NO PRODUCT DISCUSSED $29,417 |
LEMTRADA $27,500 |
AUBAGIO $22,831 |
PIPELINE-MS $100 |
$12,419 |
||
|
$73,016
OMB157G $34,004 |
FTY720D_GILENYA_NEUROSCIENCE $16,039 |
OMB157G_ARZERRA_HEMATOLOGY $8,571 |
FTY720D $3,891 |
KESIMPTA $3,226 |
Other $7,285 |
|
|
$58,698
OCREVUS $44,231 |
$14,467 |
|||||
|
$58,354
Evobrutinib $6,550 |
Mavenclad $1,407 |
$50,397 |
||||
|
$48,637
LEMTRADA $20,849 |
AUBAGIO $18,733 |
NO PRODUCT DISCUSSED $4,584 |
$4,470 |
|||
|
$195,787
OCREVUS $38,369 |
ZEPOSIA $11,556 |
COPAXONE $6,080 |
MAYZENT $5,937 |
Mavenclad $4,240 |
Other $129,605 |
| $383,899 | |
| $94,902 | |
| $38,138 | |
| $8,723 | |
| $1,097 |
Dr. Amit Bar-Or, FRCP, MD has received 58 research payments totaling $1,984,182.
Dr. Amit Bar-Or's areas of clinical interest consist of multiple sclerosis (MS) and neuroimmunology. He is professionally affiliated with The Children's Hospital of Philadelphia. He is an in-network provider for several insurance carriers, including Blue California, HealthSmart, and Coventry. Dr. Bar-Or's practice in Philadelphia, PA is open to new patients as reported by Yext. After completing medical school at McGill University Faculty of Medicine, he performed his residency at Massachusetts General Hospital. He has received distinctions including Lady Barbara Colyton Prize for Autoimmune Research; Melissa and Paul Anderson President's Distinguished Chair; and Finalist, Barancik Prize for Innovation in MS Research, NMSS.
